Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.

The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...

The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...

What next for the SCHD ETF now that analysts at Citigroup, Goldman Sachs, and HSBC have slashed their S&P 500 forecast?

Get Free Report) had its price target cut by stock analysts at UBS Group from $1,250.00 to $1,000.00 in a report released on ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized ...

OFI Invest Asset Management acquired 140,434 shares of Goldman Sachs, worth approximately $77.66 million. This investment ...

Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares ...

It’s been tough for Wall Street strategists to hold their nerve in the face of the ever-changing tariff policy.

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...

U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...

Stocks dropped as the selling pressures that dragged Wall Street last week persisted, while investors braced for a slew of ...